Introduction The prevention and treatment of blood clots, a leading cause of morbidity and mortality worldwide, have traditionally relied on a “one-size-fits-all” approach to anticoagulation therapy. However, this approach often proves inadequate, resulting in suboptimal outcomes for many patients. Dr. Abeer AbouYabis says, variations in individual genetics, comorbidities, and drug metabolism significantly impact the effectiveness and […]